Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-09-23
1989-11-28
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4241951, 424687, 424682, 424715, 514824, A61K 31715, A61K 3314, A61K 3310
Patent
active
048837881
ABSTRACT:
An orally administrable composition and method for reducing serum cholesterol levels are disclosed. A pharmaceutical composition comprising guar gum, and a dispersing mineral salt such as, for example, calcium carbonate, magnesium carbonate, or potassium carbonate, is administered to humans to reduce serum cholesterol levels.
REFERENCES:
patent: 4747881 (1988-05-01), Shaw et al.
patent: 4764374 (1988-08-01), Grimberg
Kannel, W. B., Thom T. J., "Declining CArdiovascular Mortality", Circulation 70:331-336 (1984).
National Institutes of Health Consensus Development Conference On Lowering Blood Cholesterol To Prevent Heart Disease, JAMA: 253, No. 14, 2980-2086 (1985).
Dawber, T. R., The Framingham Study, Cambridge, MA, Harvard University Press, pp. 1-13 and 121-141, (1980).
Thelle, D. S. et al., "The Tromso Heart Study: Methods and Main Results of The Cross-Sectional Study", Acta. Med. Scand., 200:107-118 (1976).
Ross, R., Glomset, J., "The Pathogenesis of Atherosclerosis", N. Engl. J. Med., 295:369-377, (1976).
Henriksen, T. Mahoney, E. M. Steinberg, D., "Interactions of Plasma Lipoproteins With Endothelial Cells", Ann. N.Y. Acad. Sci., 401:102-116 (1982).
U.S. Department of Health and Human Services: Cardiovascular Primer for the Workplace, NIH Publication No. 81-2210, pp. 1-88, esp. p. 75 (Jan. 1981).
Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease, and II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering, JAMA, 251: 351-374 (1984).
Superko, H. R., "Decreasing Blood Cholesterol Levels With a Dietary Additive: An additional Approach to Diet and Drugs", Cardiovascular Reviews & Reports, 6: No. 11,1253-1265 (Nov. 1985).
Khan, A. R. et al., "Effect of Guar Gum on Blood Lipids", The American Journal of clinical Nutrition, 34:2446-2449 (Nov. 1981).
Mokady, S., "Effect of Dietary Pectin and Algin on Blood Cholesterol Level in Growing Rats Fed a Cholesterol-Free Diet", Nutr. Metabol., 15:290-294 (1973).
Kay, R. M. et al., "Effect of Citrus Pectin on Blood Lipids and Fecal Steroid Excretion in Man", Am. J. Clin. Nutr., 30:171-175 (1977).
Johnson et al., "Effect of Gel-Forming Gums on the Intestinal Unstirred Layer and Sugar Transport in Vitro", Gut, 22:398-403 (1981).
Isaksson, G. et al., "In Vitro Inhibition of Pancreatic Enzyme Activities by Dietary Fiber", Digestion, 24:54-59 (1982).
Jenkins, D. J. et al., "Effect of Pectin, Guar Gum, and Wheat Fibre on Serum-Cholesterol", The Lancet, 1116-1117, (May 17, 1975).
Jenkins, D. J. A., "Dietary Fiber and Other Antinutrients: Metabolic Effects and Therapeutic Implications", Nutritional Pharmacology, p. 121, (1981).
Day Charles E.
Kuhrts Eric H.
Hauser-Kuhrts, Inc.
Hueschen Gordon W.
Rollins John W.
LandOfFree
Method and composition for reducing serum cholesterol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for reducing serum cholesterol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for reducing serum cholesterol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581880